Patents by Inventor Michael Wachter

Michael Wachter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR ELECTRODEPOSITING A DARK CHROMIUM LAYER, SUBSTRATE COMPRISING SAME, AND ELECTROPLATING BATH THEREOF
    Publication number: 20240271305
    Abstract: The present invention relates to a method for electrodepositing a dark chromium layer on a substrate, a respective electroplating bath for depositing such a dark chromium layer, and a respective substrate comprising said dark chromium layer. The electroplating bath comprises colloidal particles containing the chemical element aluminum. The substrate comprising said dark chromium layer is primarily suited for decorative purposes.
    Type: Application
    Filed: June 8, 2022
    Publication date: August 15, 2024
    Applicant: Atotech Deutschland GmbH & Co. KG
    Inventors: Berkem ÖZKAYA, Peter KÜHLKAMP, Oleksandra YEVTUSHENKO, Michael JONAT, Philipp WACHTER
  • METHOD FOR ADJUSTING THE BRIGHTNESS L* OF AN ELECTROPLATED CHROMIUM LAYER
    Publication number: 20240271308
    Abstract: The present invention relates to a method for adjusting the brightness L* of an electroplated chromium layer, in particular of a dark electroplated chromium layer. The method includes an aqueous trivalent chromium electroplating bath comprising colloidal particles and/or agglomerates thereof and a step of fully or partially removing same with optionally adding colloidal particles.
    Type: Application
    Filed: June 7, 2022
    Publication date: August 15, 2024
    Applicant: Atotech Deutschland GmbH & Co. KG
    Inventors: Berkem ÖZKAYA, Michael JONAT, Philipp WACHTER, Philip HARTMANN
  • Mechanical valve for waterless urinal
    Patent number: 10294650
    Abstract: A non-flushing urinal system with a large sealing and flow area using a bell-shaped valve with supporting ribs on its interior surface, which utilizes low “crack pressure,” or ease of initial opening to create for high flow rate and superior sealing.
    Type: Grant
    Filed: January 9, 2017
    Date of Patent: May 21, 2019
    Assignee: FALCON WATERFREE TECHNOLOGIES, LLC
    Inventors: Michael Wächter, Manuel Peter, Edward Michael Goldsmith
  • MECHANICAL VALVE FOR WATERLESS URINAL
    Publication number: 20170198469
    Abstract: A non-flushing urinal system with a large sealing and flow area using a bell-shaped valve with supporting ribs on its interior surface, which utilizes low “crack pressure,” or ease of initial opening to create for high flow rate and superior sealing.
    Type: Application
    Filed: January 9, 2017
    Publication date: July 13, 2017
    Inventors: Michael Wächter, Manuel Peter, Edward Michael Goldsmith
  • MANAGING CONSISTENT INTERFACES FOR A PRODUCT DESIGN VERSION HIERARCHY BUSINESS OBJECT ACROSS HETEROGENEOUS SYSTEMS
    Publication number: 20130031565
    Abstract: A business object model, which reflects data that is used during a given business transaction, is utilized to generate interfaces. This business object model facilitates commercial transactions by providing consistent interfaces that are suitable for use across industries, across businesses, and across different departments within a business during a business transaction. In some operations, software creates, updates, or otherwise processes information related to a product design version hierarchy business object.
    Type: Application
    Filed: July 28, 2011
    Publication date: January 31, 2013
    Applicant: SAP AG
    Inventors: Michael Wachter, Jens Griessmann, Thomas Kretz, Michael Belenki, Karthikeyan A, Jeyaraj A, Ranjini R Varma
  • PROVIDING FOUNDATION APPLICATION AS ENTERPRISE SERVICES
    Publication number: 20120047079
    Abstract: Methods and apparatus, including systems and computer program products, for a services architecture design that provides enterprise services having foundation layer functionality at the level of an enterprise application. The design includes a set of service operations, process components, and optionally deployment units. Suitable business objects are also described.
    Type: Application
    Filed: October 28, 2011
    Publication date: February 23, 2012
    Inventors: Thomas Biesemann, Dieter Krisch, Volker Schott, Michael Meyringer, Otfried Von Geisau, Martin Haerterich, Ralf Becker, Ingo Bruss, Horst Schaude, Silke Storch, Klaus Bahr, Volker Faisst, Ralph Moessner, Vsevolod Barabanov, Andreas Kasparek, Jens Griessmann, Hendrik Geipel, Frank Lindqvist, Oliver Grande, Ute Dittmann, Ricardo Padilha, Martin Walla, Joachim Puteick, Daniel Zimmermann, Thomas Schneider, Tilmann Haeberle, Gerald Krause, Karl-Peter Nos, Peter Schwarze, Daniel Maring, Yongbin He, Martina Lahr, Ingo Pfitzner, Shadab Shafio, Christian Haas, Olaf Schulte, Christoph Lehner, Dietmar Storz, Joachim Barnbeck, Bernhard May, Andrea Sudbrack, Michael Wachter, Thomas Kretz, Monika Kaiser, Andreas Steiner, Gurmeet Singh Dhingra, Andreas Huppert, Ashwin Reddy Yeddula, Keshav B. Desai, Tobias Traxel, Kranthi Kumar Muppala, Muttanna Sarashetti, Kritesh Vasing, Kai-Uwe Pielka, Raja Krishnamoorthy, Jyotsna Sharma, Mohit V. Gadkari, Mukesh Kumar, Toralf Grossmann, Andreas Neumann, Fabian Guenther, Jens Ruths, Matthias Richter, Walter Koller, Philipp Suenderhauf
  • MANAGING CONSISTENT INTERFACES FOR CUSTOMER PROJECT INVOICING AGREEMENT, ENGINEERING CHANGE CASE, PRODUCT DESIGN, PRODUCT DESIGN VERSION HIERARCHY, AND PROJECT EXPENSE VIEW BUSINESS OBJECTS ACROSS HETEROGENEOUS SYSTEMS
    Publication number: 20110307289
    Abstract: A business object model, which reflects data that is used during a given business transaction, is utilized to generate interfaces. This business object model facilitates commercial transactions by providing consistent interfaces that are suitable for use across industries, across businesses, and across different departments within a business during a business transaction. In some operations, software creates, updates, or otherwise processes information related to a customer project invoicing agreement, an engineering change case, a product design, a product design version hierarchy, and/or a project expense view business object.
    Type: Application
    Filed: June 15, 2010
    Publication date: December 15, 2011
    Inventors: Lohit Hosur, Volker Faisst, Otfried Von Geisau, Vytas Cirpus, Joerg Goeppert, Guang Yang, Volker Schott, Monica Reidl, Michael Seubert, Arno Mielke, Klaus Herter, Andre Doerfler, Steffen Springborn, Alexander S. Adam, Christian Fuhlbruegge, Michael Belenki, Thomas Kretz, Thomas Leichtweiss, Werner Sottong, Rudolf Winkel, Monika Kaiser, Claus Gschiermeister, Jens Griessmann, Kristina Grunewald, Michael Wachter, Werner Gnan, Thilo Kraehmer, Payal Patnaik, Tanja Rueckel
  • Quaternary salt CCR2 antagonists
    Patent number: 7799824
    Abstract: Quaternary salt compounds of Formula (I) or pharmaceutically acceptable forms thereof, which are CCR2 antagonists and are useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases in a subject in need thereof.
    Type: Grant
    Filed: June 22, 2005
    Date of Patent: September 21, 2010
    Assignee: OraPharma, Inc.
    Inventors: Bharat Lagu, Michael Wachter
  • Providing Foundation Application as Enterprise Services
    Publication number: 20100082497
    Abstract: Methods and apparatus, including systems and computer program products, for a services architecture design that provides enterprise services having foundation layer functionality at the level of an enterprise application. The design includes a set of service operations, process components, and optionally deployment units. Suitable business objects are also described.
    Type: Application
    Filed: September 18, 2008
    Publication date: April 1, 2010
    Applicant: SAP AG
    Inventors: Thomas Biesemann, Dieter Krisch, Volker Schott, Michael Meyringer, Otfried Von Geisau, Martin Haerterich, Ralf Becker, Ingo Bruss, Horst Schaude, Silke Storch, Klaus Bahr, Volker Faisst, Ralph Moessner, Vsevolod Barabanov, Andreas Kasparek, Jens Griessmann, Hendrik Geipel, Frank Lindqvist, Oliver Grande, Ute Dittmann, Ricardo Padilha, Martin Walla, Joachim Puteick, Daniel Zimmermann, Thomas Schneider, Tilmann Haeberle, Gerald Krause, Karl-Peter Nos, Peter Schwarze, Daniel Maring, Yongbin He, Martina Lahr, Ingo Pfitzner, Shadab Shafiq, Christian Haas, Olaf Schulte, Christoph Lehner, Dietmar Storz, Joachim Barnbeck, Bernhard May, Andrea Sudbrack, Michael Wachter, Thomas Kretz, Monika Kaiser, Andreas Steiner, Gurmeet Singh Dhingra, Andreas Huppert, Ashwin Reddy Yeddula, Keshav B. Desal, Tobias Traxel, Kranthi Kumar Muppala, Muttanna Sarashetti, Kritesh Vasing, Kai-Uwe Pielka, Raja Krishnamoorthy, Jyotsna Sharma, Mohit V. Gadkari, Mukesh Kumar, Toralf Grossmann, Andreas Neumann, Fabian Guenther, Jens Ruths, Matthias Richter, Walter Koller, Philipp Suenderhauf
  • TETRAHYDROTHIOPYRANO PYRAZOLE CANNABINOID MODULATORS
    Publication number: 20080085899
    Abstract: The invention relates to a CB modulator compound of Formula (I) or a pharmaceutically acceptable form thereof and a method for use in treating, ameliorating or preventing a CB receptor mediated syndrome, disorder or disease.
    Type: Application
    Filed: December 7, 2007
    Publication date: April 10, 2008
    Inventors: Fina Liotta, Huajun Lu, Mingde Xia, Michael Wachter
  • TETRAHYDRO-2H-INDAZOLE PYRAZOLE CANNABINOID MODULATORS
    Publication number: 20080058313
    Abstract: This invention is directed to a tetrahydro-2H-indazole pyrazole cannabinoid modulator compound of formula (I): or a form thereof, wherein p, R1, R2 and Ar are as herein described and * represents a chiral center, and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
    Type: Application
    Filed: February 13, 2007
    Publication date: March 6, 2008
    Inventors: Fina Liotta, Huajun Lu, Michael Wachter, Mingde Xia
  • TETRAHYDRO-1H-1,2,6-TRIAZA-AZULENE CANNABINOID MODULATORS
    Publication number: 20070259853
    Abstract: This invention is directed to a tetrahydro-1H-1,2,6-triaza-azulene cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
    Type: Application
    Filed: March 27, 2007
    Publication date: November 8, 2007
    Inventors: Mingde Xia, Fina Liotta, Michael Wachter
  • Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
    Publication number: 20070254911
    Abstract: This invention is directed to a tetrahydro-pyrazolo[3,4-c]pyridine cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
    Type: Application
    Filed: March 23, 2007
    Publication date: November 1, 2007
    Inventors: Mingde Xia, Meng Pan, Fina Liotta, Michael Wachter
  • Phospholipase C inhibitors for use in treating inflammatory disorders
    Patent number: 7262197
    Abstract: This invention is directed to heterocyclyl-substituted anilino phospholipase C inhibitor compounds useful in treating or ameliorating an inflammatory disorders and/or restenosis of the general formula (I): and enantiomers, diastereomers and pharmaceutically acceptable salts thereof. The present invention is further directed to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating conditions affected by phospholipase modulation.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: August 28, 2007
    Assignee: Janssen Pharmaceutica, N.V
    Inventors: Bharat Lagu, Kenneth Rupert, Michael Wachter
  • SUBSTITUTED DIPIPERIDINE CCR2 ANTAGONISTS
    Publication number: 20070197590
    Abstract: Substituted dipiperidine compounds of Formula (I) or a form thereof, which are CCR2 antagonists and are useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases in a subject in need thereof.
    Type: Application
    Filed: January 31, 2007
    Publication date: August 23, 2007
    Inventors: Duane DeMong, Mingde Xia, Scott Pollack, Xiaoping Zheng, James Brackley, Michael Wachter, Druie Cavender, Keith Demarest
  • Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
    Publication number: 20070191362
    Abstract: This invention is directed to a tetrahydro-cyclopentyl pyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
    Type: Application
    Filed: September 22, 2006
    Publication date: August 16, 2007
    Inventors: Fina Liotta, Mingde Xia, Michael Wachter, Scott Beers
  • Tetrahydro-pyranopyrazole cannabinoid modulators
    Publication number: 20070155723
    Abstract: This invention is directed to a tetrahydro-pyranopyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
    Type: Application
    Filed: June 21, 2006
    Publication date: July 5, 2007
    Inventors: Fina Liotta, Huajun Lu, Michael Wachter
  • Substituted 3-amido-tetrahydro-indazolyl cannabinoid modulators
    Publication number: 20070117857
    Abstract: This invention is directed to a substituted 3-amido-tetrahydro-indazolyl cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
    Type: Application
    Filed: September 18, 2006
    Publication date: May 24, 2007
    Inventors: Fina Liotta, Michael Wachter, Mingde Xia
  • SUBSTITUTED 5-HETEROARYL-1-PHENYL-PYRAZOLE CANNABINOID MODULATORS
    Publication number: 20070117858
    Abstract: This invention is directed to a substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulator compound of formula (I): or a form thereof, and methods for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
    Type: Application
    Filed: November 16, 2006
    Publication date: May 24, 2007
    Inventors: Mingde Xia, Fina Liotta, Meng Pan, Michael Wachter, Huajun Lu
  • Quaternary salt CCR2 antagonists
    Publication number: 20060293379
    Abstract: Quaternary salt compounds of Formula (I) or pharmaceutically acceptable forms thereof, which are CCR2 antagonists and are useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases in a subject in need thereof.
    Type: Application
    Filed: June 22, 2005
    Publication date: December 28, 2006
    Inventors: Bharat Lagu, Michael Wachter